Crystal structures, antioxidation and DNA binding properties of Yb(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carbaldehyde and four aroylhydrazines

X-ray crystal and other structural analyses indicate that Yb(III) and all four newly synthesized ligands can form a binuclear Yb(III) complex with a 1:1 metal to ligand stoichiometry by octacoordination at the Yb(III) center. Investigations of DNA binding properties show that all the ligands and Yb(III) complexes can bind to Calf thymus DNA through intercalations with the binding constants at the order of magnitude 10⁵–10⁷ M⁻¹, but Yb(III) complexes present stronger affinities to DNA than ligands. All the ligands and Yb(III) complexes may be used as potential anticancer drugs. Investigations of antioxidation properties show that all the ligands and Yb(III) complexes have strong scavenging effects for hydroxyl radicals and superoxide radicals but Yb(III) complexes show stronger scavenging effects for hydroxyl radicals than ligands. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Synthesis, crystal structures, and magnetic properties of new tetranuclear Cu(II) complexes of bis-bidentate Schiff-base ligands

Two tetranuclear copper(II) complexes with long rigid Schiff-base ligands [Cu₄(bmsbd)₂]·2DMF [H₂bmsbd = N,N′-bis-(3-methoxy-salicylidene)benzene-1,4-diamine] (1) and [Cu₄(besbd)₂]·DMF·5H₂O [H₂besbd = N,N′-bis-(3-methoxy-salicylidene)benzene-1,4-diamine] (2) have been synthesised and characterized. Single X-ray diffraction analysis reveals that both complexes exhibit interesting [2 × 2] molecular grid-like configuration assembled by four organic ligands in a head-to-tail mode to bind four copper(II) ions. Magnetic property investigations reveal weak antiferromagnetic interaction viaσ-bond pathway of long rigid Schiff-base ligand between the neighboring copper(II) ions in both complexes.     

Chiral and achiral macrocyclic copper(II) complexes: Synthesis, characterization, and comparative binding studies with calf-thymus DNA

The new chiral macrocyclic complexes [1,2-bis(1H-benzimidazol-2-yl)-1-(1,8-dihydro-1,3,5,8,10,12-hexaazacyclotetradecane)-2-hydroxyethanolate] copper(II) and -nickel(II) perchlorate, 3 and 4, respectively, were synthesized by the reaction of 1,2-bis(1H-benzimidazol-2-yl)ethane-1,2-diol (L) and (1,8-dihydro-1,3,5,8,10,12-hexaazacyclotetradecane)copper(II) and -nickel(II) diperchlorate complexes, 1 and 2, respectively. All complexes were characterized by various spectroscopic techniques. Molar-conductance measurements showed that all of the complexes are ionic in nature. In complexes 3 and 4, the metal center is encapsulated by the ligand L in a pentacoordinated environment. The optical-rotation values ([alpha](D)) of 3 and 4 at 25 degrees indicate that the complexes are chiral. Absorption- and fluorescence-spectral studies, cyclic voltammetry, and viscosity measurements have been carried out to assess the comparative binding of complexes 1 and 3 with calf thymus (CT)-DNA. Analysis of the results suggests that the new chiral complex 3 binds to CT-DNA through a partial intercalation mode that is different from the binding mode of parent achiral complex 1. The complexes 1 and 3 bind to CT-DNA with binding constants K(b) of 2.7 x 10(4) and 6.6 x 10(4) M(-1), respectively. Circular-dichroism (CD) studies have been further employed to ascertain the binding mode of complex 3, which is consistent with the other spectral studies.     

Synthesis, crystal structure and interaction with DNA and HSA of (N,N'-dibenzylethane-1,2-diamine) transition metal complexes

A new ligand, N,N′-dibenzylethane-1,2-diamine (L) and its four transition metal(II) complexes, ML₂(OAc)₂ · 2H₂O (M = Cu, Ni, Zn, Co), have been synthesized and characterized by elemental analysis, mass spectra, molar conductivity, NMR and IR. Moreover, the crystals structure of Cu(II) and Ni(II) complexes characterized by single crystal X-ray diffraction showed that the complexes have a similar molecular structure. Ni(II) has an regular octahedral coordination environment complexes, but typical Jahn Teller effect influenced Cu(II) in an elongated octahedral environment. The interaction between complexes and calf thymus DNA were studied by UV and fluorescence spectra measure, which showed that the binding mode of complexes with DNA is intercalation. Under physiological pH condition, the effects of Cu(OAc)₂L₂ · 2H₂O and Ni(OAc)₂L₂ · 2H₂O on human serum albumin were examined by fluorescence. The results of spectroscopic measurements suggested that the hydrophobic interaction is the predominant intermolecular force. The enthalpy change ΔH⁰ and the entropy change ΔS⁰ of Cu(OAc)₂L₂ · 2H₂O and Ni(OAc)₂L₂ · 2H₂O were calculated to be −11.533 kJ mol⁻¹ and 46.339 J mol⁻¹ K⁻¹, −11.026 kJ mol⁻¹ and 46.396 J mol⁻¹ K⁻¹, respectively, according to the Scatchard’s equation. The quenching mechanism and the number of binding site (n ≈ 1) were also obtained from fluorescence titration data.     

Mixed-ligand copper(II)-phenanthroline-dipeptide complexes: synthesis, characterization, and DNA-cleavage properties

The mixed-ligand complexes [Cu(II)(HisLeu)(phen)](+) (1) and [Cu(II)(HisSer)(phen)](+) (2; phen=1,10-phenanthroline) were synthesized and characterized. The intercalative interaction of the Cu(II) complexes with calf-thymus DNA (CT-DNA) was probed by UV/VIS and fluorescence titration, as well as by thermal-denaturation experiments, and the intrinsic binding constants (K(b)) for the complexes with 1 and 2 were 4.2x10(3) and 4.9x10(3) M(-1), resp. Both complexes were found to be efficient catalysts for the hydrolytic cleavage of plasmid pUC19 DNA, as tested by gel electrophoresis, converting the DNA from the supercoiled to the nicked-circular form at rate constants of 1.32 and 1.40 h(-1) for 1 and 2, resp.     

Dicopper(II) and dinickel(II) complexes of Schiff-base macrocycles derived from 5,5-dimethyl-1,9-diformyldipyrromethane

The synthesis and characterisation of two dicopper(II) and two dinickel(II) macrocyclic complexes, [Cu^II₂L^Pr] (10), [Cu^II₂L^Bu] (11), [Ni^II₂L^Pr] (12) and [Ni^II₂L^Bu] (13), are reported. The two new Schiff-base macrocycles (L^Pr)⁴⁻ and (L^Bu)⁴⁻ are isolated as dimetallic complexes 10-13 by the [2+2] condensation of 5,5-dimethyl-1,9-diformyldipyrromethane (9) and 1,3-diaminopropane or 1,4-diaminobutane, respectively, using Cu²⁺ or Ni²⁺ template ions. Single crystal X-ray structure determinations carried out on 10-13 show that each metal atom is in a square planar N₄ geometry, being bound to two deprotonated pyrrole nitrogen atoms of one dipyrromethane unit and to the two adjacent imine nitrogen atoms. NMR spectra obtained for the two dinickel(II) complexes 12 and 13 show that in CDCl₃ solution they are highly symmetrical and diamagnetic.     

Influence of Cr(III) and Cr(VI) on the interaction between sparfloxacin and calf thymus DNA

Cr(III) and Cr(VI) have different binding capacity with sparfloxacin, and have different combination modes with calf thymus DNA. Selecting these two different metal ions, the influence of them on the binding constants between sparfloxacin (SPFX) and calf thymus DNA, as well as the related mechanism has been studied by using absorption and fluorescence spectroscopy. The result shows that Cr(III) has weaker binding capacity to SPFX in the SPFX-Cr(III) binary system, but influences the binding between SPFX and DNA obviously in SPFX-DNA-Cr(III) ternary system. However, although Cr(VI) has a stronger binding capacity to SPFX, it has no effect on the binding between SPFX and DNA. Referring to the different modes of Cr(III) and Cr(VI) binding to DNA, the mechanism of the influence of metal ions on the binding between SPFX and DNA has been proposed. SPFX can directly bind to DNA by chelating DNA base sites. If a metal ion at certain concentration binds mainly to DNA bases, it can decrease the binding constants between SPFX and DNA through competing with SPFX. While if a metal ion at certain concentration mainly binds to phosphate groups of DNA, it can increase the binding constants by building a bridge between SPFX and DNA. If a metal ion at certain concentrations binds neither to bases nor phosphate groups in DNA, it will have no effect on the binding constant between SPFX and DNA. Our result supports Palumbo's conclusion that the binding between SPFX and the phosphata groups is the precondition for the combination between SPFX and DNA, which is stabilized through stacking interactions between the condensed rings of SPFX and DNA bases.     

Syntheses, structures, and properties of Co(III) complexes derived from polypyridine ligands containing one carboxamido nitrogen donor

Four cobalt(III) complexes containing the polypyridine pentadentate ligands N,N-bis(2-pyridylmethyl)amine-N′-ethyl-2-pyridine-2-carboxamide (PaPy₃H), N,N-bis(2-pyridylmethyl)amine-N′-[1-(2-pyridylethyl)acetamide (MePcPy₃H), and N,N-bis(2-pyridylmethyl)amine-N′-(2-pyridylmethyl)acetamide (PcPy₃H), have been synthesized. All three ligands bind the Co(III) center in the same fashion with the exception of loss of conjugation between the carboxamide moiety and the pyridine ring in the latter two. The structures of [(PaPy₃)Co(OH)][(PaPy₃)Co(H₂O)](ClO₄)₃ · 3H₂O (1), [(PaPy₃)Co(NO₂)](ClO₄) · 2MeCN (2), [(MePcPy₃)Co(MeCN)](ClO₄)₂ · 0.5MeCN (3), and [(PcPy₃)Co(Cl)](ClO₄) · 2MeCN (4) have been determined. These ligands with strong-field carboxamido N donor stabilize the +3 oxidation state of the Co center as demonstrated by the facile oxidation of the corresponding Co(II) complexes (prepared in situ) by H₂O₂, [Fe(Cp)₂](BF₄), or nitric oxide (NO). The Co-N_amido bond distances of 1-4 lie in the narrow range of 1.853-1.898 Å. ¹H NMR spectra of these complexes confirm the low-spin d⁶ ground states of the metal centers.     

Copper(II) and zinc(II) complexes with Schiff-base ligands derived from salicylaldehyde and 3-methoxysalicylaldehyde: Synthesis,crystal structures,magnetic and luminescence properties

The following Schiff bases were employed as ligands in synthesizing copper(II) and zinc(II) complexes: N-[(2-pyridyl)-methyl]-salicylimine (Hsalampy), N-[2-(N,N-dimethyl-amino)-ethyl]-salicylimine (Hsaldmen), and N-[(2-pyridyl)-methyl]-3-methoxy-salicylimine (Hvalampy). The first two ligands were obtained by reacting salicylaldehyde with 2-aminomethyl-pyridyne and N,N-dimethylethylene diamine, respectively, while the third one results from the condensation of 3-methoxysalicylaldehyde with 2-aminomethyl-pyridine. Four new coordination compounds were synthesized and structurally characterized: [Cu(salampy)(H₂O)(ClO₄)] 1, [Cu₂(salampy)₂(H₂trim)₂] 2 (H₂trim^? = the monoanion of the trimescic acid), [Cu₄(valampy)₄](ClO₄)₄ · 2CH₃CN 3, and [Zn₃(saldmen)₃(OH)](ClO₄)₂ · 0.25H₂O 4. The crystal structure of 1 consists of supramolecular dimers resulted from hydrogen bond interactions established between mononuclear [Cu(salampy)(H₂O)(ClO₄)] complexes. Compound 2 is a binuclear complex with the copper ions connected by two monoatomic carboxylato bridges arising from two molecules of monodeprotonated trimesic acid. The crystal structure of 3 consists of tetranuclear cations with a heterocubane {Cu₄O₄} core, and perchlorate ions. Compound 4 is a trinuclear complex with a defective heterocubane structure. The magnetic properties of complexes 1–3 have been investigated. Compound 4 exhibits solid-state photoluminescence at room temperature.     

Re(I)(tricarbonyl) complexes with the 2-(2-pyridyl)-N-methyl-benzimidazole, 2-(2-pyridyl)benzoxazole and 2-(2-pyridyl)benzothiazole ligands - syntheses, structures, electrochemical and spectroscopic studies

The reactions of Re(CO)₅Cl with the chelating ligands 2-(2-pyridyl)-N-methylbenzimidazole, 2-(2-pyridyl)benzoxazole and 2-(2-pyridyl)benzothiazole afforded neutral fac-Re(CO)₃(L)Cl and ionic complexes with structures confirmed by means of X-ray measurements. UV-vis absorption and emission properties have been studied at room and 77 K temperatures in order to determine the nature of the lowest electronically excited states. Electrochemical behaviour of the investigated fac-Re(CO)₃(L)Cl and complexes has been studied using cyclic and square-wave voltammetry. Preliminary results from the electrogenerated chemiluminescence studies of the ionic and the neutral fac-Re(CO)₃(MPBI)Cl complexes are briefly presented.     

Reaction of epichlorohydrin with adenosine, 2'-deoxyadenosine and calf thymus DNA: identification of adducts

Epichlorohydrin (a probable human carcinogen) was allowed to react with adenosine and the adducts were characterized by NMR and UV spectroscopy, and mass spectrometry. The adduct initially formed was 1-(3-chloro-2-hydroxypropyl)-adenosine, which subsequently ring closures to 1,N(6)-(2-hydroxypropyl)-adenosine at neutral and basic conditions. At acid conditions, the N-1 adduct undergoes a slow deamination to yield 1-(3-chloro-2-hydroxypropyl)-inosine. Minor adducts identified were 7-(3-chloro-2-hydroxypropyl)-adenosine and 3-(3-chloro-2-hydroxypropyl)-adenosine which are easily deglycosylated, and an adduct where the epichlorohydrin residue was attached to the sugar moiety of adenosine. A diadduct, 1,N(6)-(2-hydroxypropyl)-N(6)-(3-chloro-2-hydroxypropyl)-adenosine was also identified. The reaction of epichlorohydrin with calf thymus DNA gave 1,N(6)-(2-hydroxypropyl)-deoxyadenosine and 3-(3-chloro-2-hydroxypropyl)-adenine (major adduct).     

Synthesis and characterization of Eu(III) complexes with chiral Schiff base ligands derived from salicylaldehydes and amino alcohols

Optically active Schiff base ligands have been formed by the condensation of various salicylaldehydes with a series of chiral amino alcohols. The Eu(III) derivatives of these ligands were obtained as oligomeric materials, exhibiting an empirical 1:1 metal:ligand stoichiometry. The complexes were found to be somewhat soluble in chloroform, where they existed primarily as trimeric species. The optical activity experienced by the Eu(III) ion was observed to be dominated by the presence of configurational effects, corresponding to a dissymmetric arrangement of Schiff base ligands about the Eu(III) ion.     

Synthesis, and characterization of cobalt(III) complexes with Schiff bases derived from 2-hydroxynaphthaldehyde, (naph)2dien and (naph)2dpt, and monodentate amine ligands: Crystal structure, spectral and redox properties

Two series of complexes of the type [Co^III{(naph)₂dien}(amine)]BPh₄ {(naph)₂dien = bis-(2-hydroxy-1-naphthaldimine)-N-diethylenetriamine dianion, and amine = piperidine (pprdn) (1), pyrrolidine (prldn) (2), pyridine (py) (3), N-methylimidazole (N-MeIm) (4)}, and [Co^III{(naph)₂dpt}(amine)]BPh₄ {(naph)₂dpt = bis-(2-hydroxy-1-naphthaldimine)-N-dipropylenetriamine dianion, and amine = piperidine (pprdn) (5), 3-methylpyridine (3-Mepy) (6)} have been synthesized and characterized by elemental analyses, IR, UV-Vis, and ¹H NMR spectroscopy. The crystal structures of (2) and (6) have been determined by X-ray diffraction. The redox potentials of the central cobalt ion show a relatively good correlation with the σ-donor ability of the axial ligands. The spectroscopic and electrochemical properties of these complexes are also influenced by the mutual steric hindrance between the pentadentate Schiff base and the ancillary ligands.     

DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects

Four gold(III) complexes of terpyridine derivatives 1–4 have been synthesized and characterized by spectroscopic methods. In vitro data demonstrated that all of them showed higher cytotoxicity than cisplatin against the human non-small-cell lung cancer cell line (A-549), the human stomach carcinoma cell line (SGC-7901), the human cervix carcinoma cell line (HELA), the human colon carcinoma cell line (HCT-116), the human liver carcinoma cell line (BEL-7402), the murine leukemia cell line (P-388) and the human acute promyelocytic leukemia cell line (HL-60). Complex 3 exhibits the highest activity, with growth inhibition rates of over 80% at 10⁻⁸ mol L⁻¹ against the A-549, HCT-116 and HELA tumor cell lines. Interestingly, ligands L1–L4 are also very cytotoxic against the cell lines tested. Complexes 1–4 are stable in aqueous solution for 2 days in the presence of the biological reducing agent glutathione. The inductively coupled plasma mass spectrometry data showed that DNA isolated from cells treated with complexes 1 and 3 contained gold with gold-to-nucleotide ratios of approximately 1:6,400 and 1:4,900, respectively. Fluorescence titration, UV and circular dichroism analyses proved that the steric and electrostatic effects of the ligand remarkably influence the interactions of their gold(III) complexes with DNA. The DNA binding ability of the complexes has been correlated with their cytotoxicity, which could potentially provide a new rationale for the future design of terpyridine-based metal complexes with antitumor potential.Electronic Supplementary Material Supplementary material is available to authorized users in the online version of this article at .     

Phloroglucinol-bridged trinuclear complexes with three paramagnetic octahedral nickel(II) ions: Syntheses, crystal structures, and magnetic properties

Three new C₃-symmetric tritopic ligands with a central phloroglucinol bridging unit have been synthesized and characterized. The ligands are accessible through Schiff-base condensation of 2,4,6-triformylphloroglucinol with 2-aminomethylpyridine (H₃tfpg-ampy), N,N-bis(pyridin-2-ylmethyl)-ethylenediamine (H₃tfpg-unspenp), and benzhydrazide (H₆tfpg-bhy). These ligands differ in nature and number of the donor atoms within the resulting binding pockets. Based on these ligands the synthesis of the first trinuclear phloroglucinol-bridged nickel(II) complexes with three octahedrally coordinated nickel centers is reported. The ligands H₃tfpg-ampy and H₆tfpg-bhy, which provide tridentate binding pockets, react with nickel(II) perchlorate in the presence of bis(pyridin-2-ylethyl)-amine (bpea) as an additional tridentate capping ligand leading to the formation of the trinuclear complexes [Ni₃(tfpg-ampy)(bpea)₃](ClO₄)₃ and [Ni₃(tfpg-bhy)(bpea)₃](ClO₄)₃, respectively. Due to the pentadentate binding pocket in ligand H₃tfpg-unspenp, no additional coligand is needed and a water molecule occupies the sixth coordination site at the nickel(II) ion resulting in the complex [Ni₃(tfpg-unspenp)(H₂O)₃](ClO₄)₃. Temperature-dependent magnetic measurements reveal overall weak antiferromagnetic exchange interactions within the trinuclear complex together with a rather strong zero-field splitting (ZFS) for the nickel(II) ions. The observed isotropic coupling constants for the three complexes are in the range of 0.14 < − J < 0.37 cm⁻¹, whereas for the zero-field splitting parameter ∣D∣ values between 1.8 and 5.5 cm⁻¹ are found. This is indicative for competitive spin-polarization and superexchange mechanisms, with the latter prevailing the interaction between the nickel(II) ions through the meta-phenylene-linkage for the complexes reported.     

Binuclear monofunctional platinum(II) complexes formed by hexaazamacrocyclic bisdien ligands: Crystal structure, DNA binding and cytotoxicity studies

Two binuclear 3N-chelated monofunctional Pt^II complexes, [Pt₂L1Cl₂]Cl₂ (complex III) and [Pt₂L2Cl₂]Cl₂ (complex IV) [L1 = 3,6,9,16,19,22-hexaazatricyclo[22.2.2.2^11,14]-triaconta-11,13,24,26(1),27,29-hexaene, L2 = 3,6,9,17,20,23-hexaazatricyclo[23.3.1.1^11,15]-triaconta-1(29),11(30),12,14,25,27-hexaene] have been synthesized and structurally characterized. Structural determination revealed that each Pt^II center was coordinated by one chloride anion and three N atoms from each diethylenediamine motif. The Pt-Cl bonds in complex III are shorter than those found in complex IV. The rigid para- and meta-xylylene groups make the two complexes adopt a rigid boat-like conformation and a flexible twisted chair-like conformation, respectively. Moreover, complex III has higher tendency to bind with each other than complex IV. DNA binding studies demonstrated that complex IV could bind effectively with calf thymus DNA, possibly via platination of N7 of guanine residue, while no obvious DNA binding was observed for complex III. However, complex III displays a comparable cytotoxicity to cisplatin against HeLa cell line, while compound IV does not show any effective cell inhibition at low concentration. Therefore, the rigid spacers in complexes III and IV play a determining role in their anti-cancer activity and DNA binding ability.     

Synthesis and characterization of a new macrocyclic copper(II) complex with an N-glycosidic pendant arm: in vitro cytotoxicity and binding studies with calf-thymus DNA

The new macrocyclic complex 2-amino-2-deoxy-N-[2-(1,3,5,8,11-pentaazacyclotridecan-3-yl)ethyl]-beta-D-glucopyranosylamine copper(II) dichloride (1a) was prepared and thoroughly characterized by various techniques. Molar-conductance measurements showed that 1a (and its Ni analogue 1b) are ionic in nature. On the basis of spectroscopic data, both complexes were assigned a square-planar geometry, and found to be highly stabile and hydrolytically robust in H2O over a wide range of pH, as confirmed by cyclic voltammetry (CV). The Cu(II) complex 1a was found to bind to CT-DNA, with a binding constant Kb of 2.4x10(3) M(-1), as derived by UV/VIS titration, and confirmed by CV, circular dichroism (CD), and viscosity measurements. DNA binding seems to occur mostly via H-bonding. In an in vitro antitumor MTT assay, 1a exhibited significant anticancer activity against the SY5Y and PC-12 cell lines, with an estimated IC50 value in the micromolar range for SYSY, similar to the standard drug 5-fluorouracil.     

Bimetallic copper(II) and zinc(II) complexes of acyclic Schiff base ligands derived from amino acids

The acyclic Schiff-base ligands (2-(OH)-5-(R³)C₆H₂-1,3-(HCNC(R¹)(R²)CO₂H), derived from the dialdehyde 2-hydroxy-5-R-1,3-benzenedicarboxaldehyde (R = Me or t-Bu) and two equivalents of the amino acids glycine, 2,2-diphenylglycine or phenylalanine, have been reacted with the metal acetates M(OAc)₂ (M = Cu, Zn) in the presence of triethylamine, affording the complexes [HNEt₃][M₂(CH₃CO₂)₂(2-(O)-5-(t-Bu)C₆H₂-1,3-(HCNC(R¹)(R²)CO₂)₂] (M = Cu, R¹ = R² = C₆H₅, R³ = Me (1); M = Zn, R¹ = R² = H, R³ = t-Bu (2); M = Zn, R¹ = R² = C₆H₅, R³ = t-Bu (3); M = Zn, R¹ = H, R² = CH₂C₆H₅, R³ = t-Bu (4)) in good yields. The crystal structures of 1·MeCN, 2·, 3·2MeOH, and 4·3MeOH have been determined.     

Synthesis,characterization and DNA binding studies of platinum(II) complexes with benzimidazole derivative ligands

The aim of this study was to synthesize and evaluate plasmid DNA interaction of new platinum(II) complexes with some 2-substituted benzimidazole derivatives as carrier ligands which may have potent anticancer activity and low toxicity. Twelve benzimidazole derivatives carrying indole, 2-/or 3-/or 4-methoxyphenyl, 4-methylphenyl, 3,4-dimethoxyphenyl, 3,4,5-trimethoxyphenyl, 4-methoxybenzyl, 3,4,5-trimethoxybenzyl, 3,4,5-trimethoxystyryl, 3,4,5-trimethoxybenzylthio or dimethylamino ethyl groups in their position 2 and twelve platinum(II) complexes with these carrier ligands were synthesized. The chemical structure of the platinum complexes have been characterized by their elemental analysis and FIR, ¹H NMR and mass spectra and their ¹H NMR and FIR spectra were interpreted by comparison with those of the ligands. The interaction of all the ligands and their complexes with plasmid DNA and their restriction endonuclease reactions by BamHI and HindIII enzymes were studied by agarose gel electrophoresis. It was determined that complex 1 [dichloro-di(2-(1H-indole-3-yl)benzimidazole)platinum(II)·2H₂O] has stronger interaction than carboplatin and complex 10 [dichloro-di(2-(3,4,5-trimethoxystyryl)benzimidazole)platinum(II)·2H₂O] has stronger interaction than both carboplatin and cisplatin with plasmid DNA.